These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
393 related items for PubMed ID: 8377223
1. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations. Panagopoulos NT, Matsokis NA, Valcana T. J Neurosci Res; 1993 Aug 01; 35(5):499-506. PubMed ID: 8377223 [Abstract] [Full Text] [Related]
2. Kinetic and pharmacologic characterization of dopamine binding in the mouse cerebellum and the effects of the reeler mutation. Panagopoulos N, Matsokis NA, Valcana T. J Neurosci Res; 1988 Aug 01; 19(1):122-9. PubMed ID: 3343704 [Abstract] [Full Text] [Related]
3. Kinetics of dopamine and noradrenaline transport in synaptosomes from cerebellum, striatum and frontal cortex of normal and reeler mice. Efthimiopoulos S, Giompres P, Valcana T. J Neurosci Res; 1991 Aug 01; 29(4):510-9. PubMed ID: 1838778 [Abstract] [Full Text] [Related]
4. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla. Maroto R, López MG, del Valle M, Naranjo JR, Mellström B, García AG. Mol Pharmacol; 1995 Jan 01; 47(1):40-50. PubMed ID: 7838132 [Abstract] [Full Text] [Related]
5. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat. Hilakivi I, Rinne J, Marjamäki P. Pol J Pharmacol; 1999 Jan 01; 51(4):311-6. PubMed ID: 10540962 [Abstract] [Full Text] [Related]
6. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol. Hancock AA, Marsh CL. Mol Pharmacol; 1984 Nov 01; 26(3):439-51. PubMed ID: 6238230 [Abstract] [Full Text] [Related]
7. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study. Gnanalingham KK, Smith LA, Hunter AJ, Jenner P, Marsden CD. Synapse; 1993 Jun 01; 14(2):184-94. PubMed ID: 8332947 [Abstract] [Full Text] [Related]
8. Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice. Rubinstein M, Muschietti JP, Gershanik O, Flawia MM, Stefano FJ. J Pharmacol Exp Ther; 1990 Feb 01; 252(2):810-6. PubMed ID: 2138223 [Abstract] [Full Text] [Related]
9. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors. Levant B, DeSouza EB. Synapse; 1993 May 01; 14(1):90-5. PubMed ID: 8099762 [Abstract] [Full Text] [Related]
10. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease. Bennett JP, Wooten GF. Ann Neurol; 1986 Apr 01; 19(4):378-83. PubMed ID: 3707090 [Abstract] [Full Text] [Related]
11. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor. Leff SE, Creese I. Mol Pharmacol; 1985 Feb 01; 27(2):184-92. PubMed ID: 3969067 [Abstract] [Full Text] [Related]
12. D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites. Severson JA, Randall PK. J Pharmacol Exp Ther; 1985 May 01; 233(2):361-8. PubMed ID: 3158731 [Abstract] [Full Text] [Related]
13. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats. Shuto T, Seeman P, Kuroiwa M, Nishi A. Eur J Neurosci; 2008 May 01; 27(10):2551-7. PubMed ID: 18489579 [Abstract] [Full Text] [Related]
14. Chemical modification reveals involvement of tyrosine in ligand binding to dopamine D1 and D2 receptors. Srivastava LK, Mishra RK. Biochem Int; 1990 May 01; 21(4):705-14. PubMed ID: 2241996 [Abstract] [Full Text] [Related]
15. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907. Pugsley TA, Davis MD, Akunne HC, MacKenzie RG, Shih YH, Damsma G, Wikstrom H, Whetzel SZ, Georgic LM, Cooke LW. J Pharmacol Exp Ther; 1995 Dec 01; 275(3):1355-66. PubMed ID: 8531103 [Abstract] [Full Text] [Related]
16. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway. Santanavanich C, Ebadi M, Govitrapong P. J Pineal Res; 2005 Apr 01; 38(3):170-5. PubMed ID: 15725338 [Abstract] [Full Text] [Related]
17. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively. Urwyler S, Markstein R. J Neurochem; 1986 Apr 01; 46(4):1058-67. PubMed ID: 2936868 [Abstract] [Full Text] [Related]
18. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex. Chatterjee TK, Scott CE, Vazquez DM, Bhatnagar RK. Mol Pharmacol; 1988 Apr 01; 33(4):402-13. PubMed ID: 3357484 [Abstract] [Full Text] [Related]
19. Dopamine D2 receptors increase in the dorsolateral striatum of weaver mutant mice. Kaseda Y, Ghetti B, Low WC, Richter JA, Simon JR. Brain Res; 1987 Sep 29; 422(1):178-81. PubMed ID: 2960423 [Abstract] [Full Text] [Related]
20. Age-related changes in striatal dopamine D2 receptor binding in weaver mice and effects of ventral mesencephalic grafts. Kaseda Y, Ghetti B, Low WC, Norton J, Brittain H, Triarhou LC, Richter JA, Simon JR. Exp Brain Res; 1990 Sep 29; 83(1):1-8. PubMed ID: 2150046 [Abstract] [Full Text] [Related] Page: [Next] [New Search]